Blood Cancer Journal (May 2021)
Morphologic leukemia-free state in acute myeloid leukemia is sufficient for successful allogeneic hematopoietic stem cell transplant
- Cindy M. Pabon,
- Zhiguo Li,
- Therese Hennig,
- Carlos de Castro,
- Jadee L. Neff,
- Mitchell E. Horwitz,
- Thomas W. LeBlanc,
- Gwynn D. Long,
- Richard D. Lopez,
- Anthony D. Sung,
- Nelson Chao,
- Cristina Gasparetto,
- Stefanie Sarantopoulos,
- Donna B. Adams,
- Harry Erba,
- David A. Rizzieri
Affiliations
- Cindy M. Pabon
- Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University Medical Center
- Zhiguo Li
- Department of Biostatistics and Bioinfomatics, Duke University
- Therese Hennig
- Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University Medical Center
- Carlos de Castro
- Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University Medical Center
- Jadee L. Neff
- Department of Pathology, Divisions of Hematopathology and Molecular Pathology, Genetics and Genomics
- Mitchell E. Horwitz
- Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University Medical Center
- Thomas W. LeBlanc
- Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University Medical Center
- Gwynn D. Long
- Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University Medical Center
- Richard D. Lopez
- Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University Medical Center
- Anthony D. Sung
- Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University Medical Center
- Nelson Chao
- Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University Medical Center
- Cristina Gasparetto
- Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University Medical Center
- Stefanie Sarantopoulos
- Donna B. Adams
- Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University Medical Center
- Harry Erba
- Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University Medical Center
- David A. Rizzieri
- Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University Medical Center
- DOI
- https://doi.org/10.1038/s41408-021-00481-9
- Journal volume & issue
-
Vol. 11,
no. 5
pp. 1 – 4
Abstract
No abstracts available.
